JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
24h
Actual
Mínimo
2.5
Máximo
2.57
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +464.2% upside |
Próximas Ganancias | 12 nov 2025 |
|---|
Resultados pasados no son un indicador fiable de resultados futuros.
1 oct 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Leer
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 Meses
Media 14.5 USD 464.2%
Máximo 17 USD
Mínimo 12 USD
De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Mantener
0
Vender
De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$